BioLife Solutions (NASDAQ:BLFS) reported quarterly sales of $44.26 million which beat the analyst consensus estimate of $43.28 million by 2.26 percent. This is a 18.64 percent increase over sales of $37.30 million the same period last year.
Sagaliam Acquisition Corp. Confirms Funding And Extension Of Deadline To Complete Initial Business Combination To January 23, 2023
Sagaliam Acquisition Corp. (NASDAQ: "SAGAU", "SAGA", "SAGAR") ("we", "us", "our", or the "Company") announced today that it was exercising its
